Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Pharmaceuticals in Russia

Be the first to review this product

Summary
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The...
You can choose to pay by purchase order during checkout

Availability: In stock

$350.00

* Required Fields

You can choose to pay by purchase order during checkout
Marketline

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Summary
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
 Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia

 Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia

 Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

 Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
 What was the size of the Russia pharmaceuticals market by value in 2015?

 What will be the size of the Russia pharmaceuticals market in 2020?

 What factors are affecting the strength of competition in the Russia pharmaceuticals market?

 How has the market performed over the last five years?

 Who are the top competitors in Russia's pharmaceuticals market?

Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Russian pharmaceuticals market had total revenues of $16.9bn in 2015, representing a compound annual growth rate (CAGR) of 21.6% between 2011 and 2015.

The Russian market is largely controlled by the commercial segment, rather than government purchasing. In contrast, the majority of EU countries compensate 65-80 percent of patients' expenses incurred on purchasing most prescribed medicines, meaning that this section of the market is the driver. Coupled with this, Russia has much fewer active pharmacies than many of its European neighbours with double the number of patients per pharmacy, which indicates the capacity for growth.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 8% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $24.9bn by the end of 2020.

Additional Information

Additional Information

Publisher name Marketline
Format Industry Profile
Page count 38
Publication date 26 Sep 2016
Table of contents Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register